SCHEMBL4074072

SCHEMBL4074072

C1CCN2CCNC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7222730 1.00
SCHEMBL7223129 1.00
SCHEMBL4073054 0.98 HTR6 (0.43)
SCHEMBL4069566 0.92
SCHEMBL1181468 0.90 HTR6 (0.40)
SCHEMBL22628194 0.90 HTR6 (0.40)
SCHEMBL9388849 0.90 HTR6 (0.40)
SCHEMBL6817248 0.88 HTR6 (0.39)
SCHEMBL548524 0.88 HTR6 (0.39)
SCHEMBL5241137 0.88 HTR6 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3281933-B1 (METH)ACRYLATE MANUFACTURING METHOD TOAGOSEI CO LTD (JP) 2020-08-19 EP disclosed
US-10619058-B2 Curable composition TOAGOSEI CO., LTD. (JP) 2020-04-14 US disclosed
US-10611856-B2 Curable composition TOAGOSEI CO., LTD. (JP) 2020-04-07 US disclosed
EP-3133058-B1 MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD TOAGOSEI CO LTD (JP) 2019-05-29 EP disclosed
US-10266476-B2 (Meth)acrylate manufacturing method TOAGOSEI CO., LTD. (JP) 2019-04-23 US disclosed
US-10065916-B2 Method for producing (meth)acrylate TOAGOSEI CO., LTD (JP) 2018-09-04 US disclosed
US-20180237629-A1 CURABLE COMPOSITION TOAGOSEI CO., LTD. (JP) 2018-08-23 US disclosed
US-10035752-B2 Multifunctional (meth)acrylate manufacturing method TOAGOSEI CO., LTD. (JP) 2018-07-31 US disclosed
US-20180187026-A1 CURABLE COMPOSITION TOAGOSEI CO., LTD. (JP) 2018-07-05 US disclosed
US-20180171038-A1 CURABLE COMPOSITION TOAGOSEI CO., LTD. (JP) 2018-06-21 US disclosed
US-9062078-B2 Substituted 7-azabicyles and their use as orexin receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2015-06-23 US disclosed
US-20140309220-A1 BENZOXAZINES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2014-10-16 US disclosed
US-20140275065-A1 SUBSTITUTED 7-AZABICYLES AND THEIR USE AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-09-18 US disclosed
US-8506913-B2 Acidic gas absorbent, acidic gas removal device, and acidic gas removal method KABUSHIKI KAISHA TOSHIBA (JP) 2013-08-13 US disclosed
US-20130037785-A1 LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE SEIKO EPSON CORPORATION (JP) 2013-02-14 US disclosed
US-20130037785-A1 LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE SEIKO EPSON CORPORATION (JP) 2013-02-14 US disclosed
EP-2554243-A1 ACIDIC GAS ABSORBENT, ACIDIC GAS REMOVAL DEVICE, AND ACIDIC GAS REMOVAL METHOD Kabushiki Kaisha Toshiba (JP) 2013-02-06 EP disclosed
US-20120294785-A1 ACIDIC GAS ABSORBENT, ACIDIC GAS REMOVAL DEVICE, AND ACIDIC GAS REMOVAL METHOD KABUSHIKI KAISHA TOSHIBA (JP) 2012-11-22 US disclosed
US-20090325992-A1 COMPOUND HAVING CYCLIC GROUP BOUND THERETO THROUGH SPIRO BINDING AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2055705-A1 COMPOUND HAVING CYCLIC GROUP BOUND THERETO THROUGH SPIRO BINDING AND USE THEREOF Ono Pharmaceutical CO., LTD. (JP) 2009-05-06 EP disclosed